Article
Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review.
Medicine - 27 Jan 2023
Chen Xiaoli, Li Dongmei, Miao Kun, Shou Tao, Zhang Wenjing
Abstract excerpt
RATIONALE: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are commonly used in the treatment of advanced non-small cell lung cancer. However, patients will inevitably develop resistance to EGFR-TKIs in the long-term treatment process. In this paper, we report a case of small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma. We summarize the characteristics...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
